ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Japan and UK eye fall launch for $20bn global vaccine alliance

Partners aim to counter financial power of US and China to secure deals

TOKYO -- Japan, the U.K. and more than 70 other countries plan to form an alliance this fall to jointly procure 2 billion doses of coronavirus vaccines by 2021, looking to gain financial leverage in talks with pharmaceutical companies. 

The partnership, initially pitched around June by Japan, the U.K., Germany, France and the European Union, aims to pool up to $20 billion. The alliance, named Covax, will pay vaccine makers in advance and procure doses for member countries. Supplies for individual nations will be capped at 20% of the population.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more